Scilex Holding (SCLX) Operating Expenses (2020 - 2026)

Scilex Holding (SCLX) posted quarterly Operating Expenses of $40.8 million for Q1 2026, up 23.95% year-over-year from $32.9 million in Q1 2025, and down 64.81% on a QoQ basis from $115.9 million in Q4 2025.

Scilex Holding (SCLX) Operating Expenses (2020 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Operating Expenses for 7 consecutive years, with $40.8 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Operating Expenses rose 23.95% year-over-year to $40.8 million; the TTM figure through Mar 2026 stood at $384.1 million (up 169.52% YoY), while the FY2025 annual figure was $376.3 million, up 168.78% from the prior year.
  • Operating Expenses came in at $40.8 million for Q1 2026 at Scilex Holding, down from $115.9 million in the prior quarter.
  • The five-year high for Operating Expenses was $197.1 million in Q3 2025, with the low at $15.6 million in Q1 2022.
  • Average Operating Expenses over 5 years is $46.9 million, with a median of $32.9 million recorded in 2025.
  • The largest YoY upside for Operating Expenses was 11168.15% in 2022 against a maximum downside of 52.42% in 2022.
  • Year by year, Operating Expenses stood at $31.7 million in 2022, then grew by 0.45% to $31.8 million in 2023, then surged by 36.09% to $43.3 million in 2024, then jumped by 167.76% to $115.9 million in 2025, then tumbled by 64.81% to $40.8 million in 2026.
  • According to Business Quant data, Operating Expenses over the past three periods registered $40.8 million, $115.9 million, and $197.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 6.72 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 9.59 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 11.01 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -8.41 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 19.82 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 5.95 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 4.37 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 5.50 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn 40.78 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 40.78 Mn
Dec 31, 2025 115.88 Mn
Sep 30, 2025 197.07 Mn
Jun 30, 2025 30.40 Mn
Mar 31, 2025 32.90 Mn
Dec 31, 2024 43.28 Mn
Sep 30, 2024 34.35 Mn
Jun 30, 2024 31.99 Mn
Mar 31, 2024 30.36 Mn
Dec 31, 2023 31.80 Mn
Sep 30, 2023 48.92 Mn
Jun 30, 2023 35.40 Mn
Mar 31, 2023 36.06 Mn
Dec 31, 2022 31.66 Mn
Sep 30, 2022 21.99 Mn
Jun 30, 2022 19.40 Mn
Mar 31, 2022 15.62 Mn
Dec 31, 2021 66.53 Mn
Sep 30, 2021 283,346.00
Jun 30, 2021 172,140.00